ZestVib

Alex Wong / Getty ImagesRon Paul holds a campaign event in Virginia in early 2012. Most people have hobbies: golf, model trains, restoring old cars, whatever. A year after Ron Paul announced his Republican presidential bid, I have concluded that his supporters must not do these things. They can’t possibly have the time. While others are at rest or at play, Paul’s supporters are on the Internet, googling his name and diving into the comments sections of news articles to register their opinions.

You have probably already seen the work of Bùi Tường Phong. A Vietnamese computer scientist working in the United States in 1973, Bùi Tường developed the Phong shading and reflection algorithms, which have been ubiquitous in computer-generated movies and 3D video games for the last 50 years. Bùi Tường’s algorithms excelled at depicting plastics, and are one reason that the film Toy Story (1995), the first entirely computer-animated feature film, was about toys.

Abolition in America stood at a crossroads in the mid-1830s. Reviled in the national press, denounced by demagogues, and attacked by mobs, abolitionists faced unprecedented hostility and violence coordinated by Southerners and their sympathizers in the North. In this climate, the silk merchants Arthur and Lewis Tappan—who provided the financial muscle behind abolition in the Northeast and had helped bring it to prominence through the recently formed American Anti-Slavery Society— realized the anti-slavery movement needed a new direction.

Cows are not the problem. It’s the way they’re managed and farmed that is creating a climate problem, says Peter Byck, a professor of practice at Arizona State University’s sustainability school and producer of the 2020 short film series Carbon Cowboys and most recently, Roots So Deep. “I’ve found examples of ranches in the U.S. that are adding to their herd, and yet, reducing their carbon footprint through regenerative practices. So, cows can actually be part of the solution to climate change, when regeneratively grazed.

Artist Statement Title: Chicken or Egg This image is about technology versus nature. The conversation is everywhere, from agriculture, science, and medicine, to AI-generated art. This image takes the age-old question of which came first, the chicken or the egg, and re-imagines it. At first, we see that the question might be settled here, that the egg ‘projects’ the chicken, so clearly, the egg comes first. However, the image of the chick that the egg projects existed first, so perhaps it is the chicken?

Common sense tells us — or ought to tell us — not to believe the pre-release gossip that accretes around expensive, commercially chancy movies starring actors who have found themselves on the tabloid hit lists. Case in point: Valkyrie. It is the true story of the June 1944 plot to assassinate Hitler, which is largely unknown to today's popular audience, and which involves a lot of high-ranking German officers standing around in their smart uniforms, discussing their plans.

This morning, I made scrambled eggs on a $129 frying pan. Most of my cookware costs a fraction of that. For years, I bought pots and pans at T.J. Maxx or other discount stores.  The frying pan I used most frequently sells on Amazon for about $30. But I cook a fair amount from home these days, and I decided it was time to splurge on a pan from Made In, a brand that is seemingly everywhere and sells expensive cookware it bills as professional quality.

There are those who, since October 7, have voiced their support for the “Palestinian cause.” There are others who, as in Paris on Nov. 12, marched in silence, chanting no slogans and refraining from supporting one “side” or the other. As for me, I support Israel. Like the well-intentioned women and men who marched in Paris “for unity and peace,” I mourn every civilian struck down in this awful war.

The latest buzzy diabetes drug semaglutide—better known by brand names Ozempic, Wegovy, and Rybelsus—is drawing attention for its ability to both control blood sugar and cause weight loss. But doctors and patients are anticipating that the most powerful of these drugs is yet to come, since the U.S. Food and Drug Administration is considering approving Eli Lilly’s drug tirzepatide (brand name: Mounjaro) for weight loss later this year. In studies Lilly submitted to the FDA, the company showed that Mounjaro—which is already approved for treating Type 2 diabetes—can lower body mass among users at its highest dose by up to 15%.